Oprah Winfrey is opening up about her experience using weight-loss drugs. The media mogul is sharing some of the realizations she has found after being under an undisclosed GLP-1, which is a type 2 ...

Oprah Winfrey has sparked controversy after making a provocative statement about 'thin people' while discussing her own weight-loss journey.While conversing with Dr. Ania Jastreboff on The Oprah ...

Oprah Winfrey has changed her perceptions of "thin people" after taking weight loss medication. The 70-year-old talk show host has seen her ...

The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.

Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.

American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

Reflecting on her public journey, Winfrey shared the emotional toll of tabloid exploitation and societal judgment.

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.

Oprah Winfrey has said taking weight-loss medication changed her preconceptions about “thin people”. The billionaire, 69, who confirmed she uses an unnamed drug as a tool to manage her weight after ...

All these years I thought that thin people — those people — just had more willpower,” Winfrey said on her podcast.

American chat show host Oprah Winfrey came under fire last year after finally confessing her weight-loss was thanks to ...

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...